Hexagon Capital Partners LLC Gsk PLC Transaction History

Hexagon Capital Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$42.05 - $47.77 $25,860 - $29,378	-615 Closed	0 $0
Q1 2022 Apr 13, 2022	SELL	$40.23 - $47.74 $4,143 - $4,917	-103 Reduced 14.35%	615 $27,000
Q4 2021 Jan 27, 2022	SELL	$38.88 - $45.31 $5,404 - $6,298	-139 Reduced 16.22%	718 $32,000
Q2 2021 Aug 11, 2021	SELL	$36.52 - $41.46 $55,912 - $63,475	-1,531 Reduced 64.11%	857 $34,000
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $11,857 - $13,843	-346 Reduced 12.66%	2,388 $85,000
Q4 2020 Feb 05, 2021	SELL	$34.07 - $39.94 $2,453 - $2,875	-72 Reduced 2.57%	2,734 $100,000
Q3 2020 Nov 10, 2020	BUY	$38.11 - $42.99 $106,936 - $120,629	2,806 New	2,806 $96,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $83.1B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Hexagon Capital Partners LLC with notifications on news.